首页 | 本学科首页   官方微博 | 高级检索  
     


The Relationship between Coronary Collateral Circulation and Neutrophil/Lymphocyte Ratio in Patients with Coronary Chronic Total Occlusion
Authors:Alper Bugra Nacar  Ali Erayman  Mustafa Kurt  Eyup Buyukkaya  Mehmet Fatih Karaka?   Adnan Burak Akcay  Sule Buyukkaya  Nihat Sen
Affiliation:aDepartment of Cardiology, School of Medicine, Mustafa Kemal University, Hatay, Turkey;bDepartment of Cardiology, Antakya State Hospital, Hatay, Turkey
Abstract:

Objectives

To investigate the relationship between neutrophil/lymphocyte ratio (NLR) and coronary collateral circulation (CCC) in patients with coronary chronic total occlusion.

Subjects and Methods

Our study population consisted of 275 consecutive patients with chronic total occlusion. One hundred and thirty-eight patients with chronic total occlusion were included in the study. They were classified into 2 groups as follows: impaired CCC (group 1: Rentrop grades 0-1) and good CCC (group 2: Rentrop grades 2-3). The NLR was calculated from the complete blood count.

Results

The NLR values of the patients with impaired CCC (4.5 ± 0.7) were significantly higher than of those with good CCC (2.7 ± 0.6, p < 0.001). In the multivariate logistic regression test, NLR (OR 33.36, 95% CI 8.189-135.7, p < 0.001), high-sensitivity C-reactive protein (hs-CRP; OR 2.152, 95% CI 1.226-3.777, p = 0.008), estimated glomerular filtration rate (OR 1.167, 95% CI 1.049-1.298, p = 0.004) and systolic blood pressure (OR 1.068, 95% CI 1.009-1.1310, p = 0.025) were independent predictors of impaired CCC. The NLR value >3.55 yielded an area under the curve value of 0.957 (95% CI 0.921-0.992, p < 0.001) and demonstrated a sensitivity of 95% and a specificity of 90% for the prediction of CCC. A moderate correlation between NLR and hs-CRP was observed (r = 0.443; p < 0.001).

Conclusion

Our findings reveal that NLR correlates with the impaired development of coronary collaterals.Key Words: Neutrophil/lymphocyte ratio, Coronary collateral circulation, Chronic total occlusion
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号